CGEM Operating Cash Flow (Statement)
Cullinan Therapeutics Inc · Operating Cash Flow (Statement)
CGEM Operating Cash Flow (Statement)
Latest reported-$159.25Mperiod ending
CGEM Cash from Operations (-$13.55M → -$159.25M)
Annual operating cash flow (statement)
High-resolution chart · PNG
CGEM operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -175,750,000 | |
| -145,303,000 | |
| -134,275,000 | |
| -126,664,000 | |
| -43,433,000 | |
| -29,772,000 | |
| -20,897,000 | |
| -13,549,000 |